Latest University of Pennsylvania School of Medicine Stories
CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day.
A third of breast cancer survivors who received the breast-conserving treatments lumpectomy and radiation rate the appearance of their post-treatment breast as only "fair" or "poor" in comparison to their untreated breast.
Taking a cue from the world of business-performance experts and baseball talent scouts, Penn Medicine translational medicine researchers are among the first to find a way to measure the productivity of collaborations in a young, emerging institute.
Defining of novel mechanism informs understanding of cancer, aging physiology.
Soccer referees may have an unconscious bias towards calling fouls based on a play's direction of motion.
A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study.
An Ethical and Clinical Exploration of the Pros & Cons of Robotic Surgery PHILADELPHIA, June 11 /PRNewswire-USNewswire/ -- Robotic surgery -- is it truly an advance for modern medicine, or just a product of slick consumer advertising campaigns and targeted marketing to physicians? Advocates say robots help surgeons perform surgery with greater access, visibility and precision all which reduce pain and blood loss, shortening hospital stays and ultimately getting patients back to work and...
Penn Also Stands among the Top Five Nationally for Pediatrics, Women's Health, Internal Medicine and Drug/Alcohol Abuse PHILADELPHIA, April 15 /PRNewswire-USNewswire/ -- The University of Pennsylvania School of Medicine has been ranked #2 among the nation's research-oriented medical schools, according to the annual survey by U.S.
PHILADELPHIA, March 18 /PRNewswire-USNewswire/ -- The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.
A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the FDA.